Zhongzhu Medical Holdings Co Ltd Total Liabilities

Latest as of March 2026: CN¥341.90 Million CNY ≈ $50.03 Million USD

Zhongzhu Medical Holdings Co Ltd total liabilities. Based on the latest financial reports, Zhongzhu Medical Holdings Co Ltd (600568) has total liabilities worth CN¥341.90 Million CNY (≈ $50.03 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Zhongzhu Medical Holdings Co Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Zhongzhu Medical Holdings Co Ltd (1998–2025)

Total liabilities of Zhongzhu Medical Holdings Co Ltd from 1998 to 2025. This chart illustrates how Zhongzhu Medical Holdings Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Zhongzhu Medical Holdings Co Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.

Zhongzhu Medical Holdings Co Ltd Competitors by Total Liabilities

The table below lists competitors of Zhongzhu Medical Holdings Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Shanghai Join Buy Co Ltd
SHG:600838
China CN¥125.27 Million
Zhejiang Shengyang Science
SHG:603703
China CN¥1.28 Billion
GeoPark Ltd
NYSE:GPRK
USA $925.50 Million
Song Da Urban & Industrial Zone Investment and Development JSC
VN:SJS
Vietnam ₫4.37 Trillion
RVRC Holding AB
ST:RVRC
Sweden Skr371.00 Million
JinkoSolar Holding Co. Ltd
F:ZJS1
Germany €95.35 Billion
Qian Jiang Water Resources Development Co Ltd
SHG:600283
China CN¥5.65 Billion
Chimera Investment Corporation
NYSE:CIM
USA $13.63 Billion

Liability Composition Analysis (1998–2025)

This chart breaks down Zhongzhu Medical Holdings Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Zhongzhu Medical Holdings Co Ltd.

Liquidity & Leverage Metrics

Zhongzhu Medical Holdings Co Ltd Total Liabilities Ratios Explained

Zhongzhu Medical Holdings Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 3.50 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.21 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.18 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Zhongzhu Medical Holdings Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Zhongzhu Medical Holdings Co Ltd (1998–2025)

The table below shows the annual total liabilities of Zhongzhu Medical Holdings Co Ltd from 1998 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥343.56 Million
≈ $50.27 Million
-9.08%
2024-12-31 CN¥377.87 Million
≈ $55.29 Million
-11.79%
2023-12-31 CN¥428.35 Million
≈ $62.68 Million
-44.80%
2022-12-31 CN¥775.97 Million
≈ $113.55 Million
+6.41%
2021-12-31 CN¥729.24 Million
≈ $106.71 Million
+33.70%
2020-12-31 CN¥545.44 Million
≈ $79.82 Million
-38.61%
2019-12-31 CN¥888.46 Million
≈ $130.01 Million
-34.79%
2018-12-31 CN¥1.36 Billion
≈ $199.37 Million
+21.04%
2017-12-31 CN¥1.13 Billion
≈ $164.71 Million
+0.05%
2016-12-31 CN¥1.13 Billion
≈ $164.63 Million
-31.69%
2015-12-31 CN¥1.65 Billion
≈ $240.99 Million
-16.01%
2014-12-31 CN¥1.96 Billion
≈ $286.93 Million
+34.12%
2013-12-31 CN¥1.46 Billion
≈ $213.94 Million
+19.26%
2012-12-31 CN¥1.23 Billion
≈ $179.39 Million
+3.90%
2011-12-31 CN¥1.18 Billion
≈ $172.65 Million
-14.61%
2010-12-31 CN¥1.38 Billion
≈ $202.19 Million
+83.01%
2009-12-31 CN¥755.02 Million
≈ $110.48 Million
-27.76%
2008-12-31 CN¥1.05 Billion
≈ $152.94 Million
+28.44%
2007-12-31 CN¥813.71 Million
≈ $119.07 Million
-1.79%
2006-12-31 CN¥828.56 Million
≈ $121.24 Million
+0.55%
2005-12-31 CN¥824.06 Million
≈ $120.59 Million
+192.06%
2004-12-31 CN¥282.16 Million
≈ $41.29 Million
+192.35%
2003-12-31 CN¥96.51 Million
≈ $14.12 Million
+187.79%
2002-12-31 CN¥33.54 Million
≈ $4.91 Million
+24.93%
2001-12-31 CN¥26.84 Million
≈ $3.93 Million
-48.38%
2000-12-31 CN¥52.00 Million
≈ $7.61 Million
+16.89%
1999-12-31 CN¥44.49 Million
≈ $6.51 Million
-2.83%
1998-12-31 CN¥45.79 Million
≈ $6.70 Million
--

About Zhongzhu Medical Holdings Co Ltd

SHG:600568 China Drug Manufacturers - Specialty & Generic
Market Cap
$612.40 Million
CN¥4.19 Billion CNY
Market Cap Rank
#10886 Global
#2962 in China
Share Price
CN¥2.10
Change (1 day)
+0.96%
52-Week Range
CN¥1.94 - CN¥3.21
All Time High
CN¥9.91
About

Zhongzhu Healthcare Holding Co.,Ltd engages in the research and development, production, and sale of drugs in China. The company offers Ophthalmic drugs, including pearl brightening eye drops, clindamycin phosphate for injection, acyclovir dispersible tablets, sodium cromoglycate eye drops, acyclovir for injection, diclofenac sodium suppositories, diclofenac sodium liniment, azithromycin granules… Read more